$LGND

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3m)
Win rate (3m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$LGNDSEC Form 4bearish
Haas Jason · LIGAND PHARMACEUTICALS INC · 2h agono track record yet
Sold 7,138 @ $292.81 avg · $2,090,062 · 2026-08-12

Form 4: Haas Jason sold LGND

Haas Jason (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 7,138 shares of LGND at an average $292.81, roughly $2,090,062, in a Form 4 filed 2026-08-14.

View filing on SEC.gov →

End of results.